Innovation in Neurosurgery

May 5, 2016, 4:30 - 6:00 PM

Event Description

If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? How novel must the technique be, before specific consent is required from the patient? When should regulatory authorities review the technique?

We discussed these questions and more with two neurosurgeons experienced in innovation, bioethics, the law, and international regulation.

Speakers

  • Joseph Madsen, MD, Director, Epilepsy Surgery, Children's Hospital Boston

  • Marieke Broekman MD, PhD, JD, Neurosurgery, University Medical Center Utrecht

Ways to Join

This event was free and open to the public.

Twitter: Follow @HMSbioethics on Twitter and join the conversation using #neuroethx

Neuroethics Seminar Series

This event is part of a series hosted by the Center for Biothics at Harvard Medical School. For more information, visit the website.

Co-sponsors

  • The International Neuroethics Society

  • The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Center for Law, Brain and Behavior, MGH

  • Institute for the Neurosciences, BWH

  • Center for Brain Science, Harvard University

  • Department of Neurobiology, Harvard Medical School

With funding from

  • Mind Brain Behavior Interfaculty Initiative, Harvard University

  • The Harvard Brain Initiative Collaborative Seed Grant Program